The Pringle manoeuvre should be avoided in hepatectomy for cancer patients due to its side effects on tumor recurrence and worse prognosis

Medical Hypotheses

Volumn 72, Issue 4, 2009, Pages 398-401

  Xiaobin, Feng ^a   Zipei, Liu ^c   Shuguo, Zheng ^a   Jiahong, Dong ^b   Xiaowu, Li ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c 306 HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; CANCER PATIENT; CELL FUNCTION; HEMODYNAMICS; HUMAN; IMMUNOREACTIVITY; ISCHEMIA; LIVER CANCER; LIVER CELL DAMAGE; LIVER RESECTION; LONG TERM CARE; METABOLIC CAPACITY; METASTASIS; MICROVASCULATURE; OUTCOME ASSESSMENT; PRINGLE MANOEUVRE; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; SURGICAL TECHNIQUE; TUMOR CELL; TUMOR PROMOTION; TUMOR RECURRENCE;

HEPATECTOMY; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PROGNOSIS;

ANIMALIA;

EID: 60449098294     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.11.029     Document Type: Article

References (67)

1. Wu M.C. Clinical research advances in primary liver cancer. World J Gastroenterol 4 (1998) 471-474
2. Harada T., Shigemura T., Kodama S., Higuchi T., Ikeda S., and Okazaki M. Hepatic resection is not enough for hepatocellular carcinoma. A follow-up study of 92 patients. J Clin Gastroenterol 14 (1992) 245-250
3. Yamamoto J., Kosuge T., Takayama T., Shimada K., Yamasaki S., Ozaki H., et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83 (1996) 1219-1222
4. Delva E., Camus Y., Nordlinger B., Hannoun L., Parc R., Deriaz H., et al. Ann Surg 209 (1989) 211-218
5. Stephenson K.R., Steinberg S.M., Hughes K.S., Vetto J.T., Sugarbaker P.H., and Chang A.E. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 208 (1988) 679-687
6. Rudiger H.A., Kang K.J., Sindram D., Riehle H.M., and Clavien P.A. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg 235 (2002) 400-407
7. Torzilli G., Makuuchi M., and Inoue K. The vascular control in liver resection: revisitation of a controversial issue. Hepatogastroenterology 49 (2002) 28-31
8. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) G15-26
9. Peralta C., Bartrons R., Riera L., Manzano A., Xaus C., Gelpi E., et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 279 (2000) G163-171
10. Serracino-Inglott F., Habib N.A., and Mathie R.T. Hepatic ischemia-reperfusion injury. Am J Surg 181 (2001) 160-166
11. Glanemann M., Vollmar B., Nussler A.K., Schaefer T., Neuhaus P., and Menger M.D. Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 38 (2003) 59-66
12. Pannen B.H. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 94 (2002) 1448-1457
13. Clavien P.A., Yadav S., Sindram D., and Bentley R.C. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232 (2000) 155-162
14. Doi K., Horiuchi T., Uchinami M., Tabo T., Kimura N., Yokomachi J., et al. Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res 105 (2002) 243-247
15. van der Bilt J.D., Kranenburg O., Nijkamp M.W., Smakman N., Veenendaal L.M., Te Velde E.A., et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 42 (2005) 165-175
16. Picardo A., Karpoff H.M., Ng B., Lee J., Brennan M.F., and Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124 (1998) 57-64
17. Ikeda Y., Matsumata T., Takenaka K., Sasaki O., Soejima K., and Sugimachi K. Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21 (1995) 188-190
18. Man K., Ng K.T., Lo C.M., Ho J.W., Sun B.S., Sun C.K., et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways. Liver Transpl 13 (2007) 1669-1677
19. Man K., Lo C.M., Xiao J.W., Ng K.T., Sun B.S., Ng I.O., et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 247 (2008) 1049-1057
20. Lo C.M., Fan S.T., Liu C.L., Chan S.C., Ng I.O., and Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94 (2007) 78-86
21. Kulik L., and Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 127 (2004) S277-S282
22. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., and Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
23. Nagasue N., Uchida M., Kubota H., Hayashi T., Kohno H., and Nakamura T. Cirrhotic livers can tolerate 30 minutes ischaemia at normal environmental temperature. Eur J Surg 161 (1995) 181-186
24. Fan S.T., Lai E.C., Lo C.M., Chu K.M., Liu C.L., and Wong J. Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg 83 (1996) 117-120
25. Yamaoka Y., Morimoto T., Inamoto T., Tanaka A., Honda K., Ikai I., et al. Safety of the donor in living-related liver transplantation - an analysis of 100 parental donors. Transplantation 59 (1995) 224-226
26. Taniguchi H., Takahashi T., Shioaki Y., Itoh A., and Oguro A. Vascular inflow exclusion and hepatic resection. Br J Surg 79 (1992) 672-675
27. Pringle J.H. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48 (1908) 541-549
28. Arnoletti J.P., and Brodsky J. Reduction of transfusion requirements during major hepatic resection for metastatic disease. Surgery 125 (1999) 166-171
29. Bismuth H., and Majno P.E. Hepatobiliary surgery. J Hepatol 32 (2000) 208-224
30. Belghiti J., Noun R., Zante E., Ballet T., and Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 224 (1996) 155-161
31. Clavien P.A., Emond J., Vauthey J.N., Belghiti J., Chari R.S., and Strasberg S.M. Protection of the liver during hepatic surgery. J Gastrointest Surg 8 (2004) 313-327
32. Bulkley G.B. Preconditioning for protection from ischemic injury: discriminating cause from effect from epiphenomenon. Ann Surg 232 (2000) 163-165
33. Chouker A., Schachtner T., Schauer R., Dugas M., Lohe F., Martignoni A., et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth 93 (2004) 204-211
34. Vollmar B., Glasz J., Leiderer R., Post S., and Menger M.D. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145 (1994) 1421-1431
35. Jaeschke H., Farhood A., and Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4 (1990) 3355-3359
36. Martinez-Mier G., Toledo-Pereyra L.H., McDuffie J.E., Warner R.L., and Ward P.A. Neutrophil depletion and chemokine response after liver ischemia and reperfusion. J Invest Surg 14 (2001) 99-107
37. Lentsch A.B., Kato A., Yoshidome H., McMasters K.M., and Edwards M.J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32 (2000) 169-173
38. Ginsburg I. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 63 (1998) 518-519
39. Kang K.J., Jang J.H., Lim T.J., Kang Y., Park K.K., Lee I.S., et al. Optimal cycle of intermittent portal triad clamping during liver resection in the murine liver. Liver Transpl 10 (2004) 794-801
40. Kimura N., Muraoka R., Horiuchi T., Tabo T., Uchinami M., Yokomachi J., et al. Intermittent hepatic pedicle clamping reduces liver and lung injury. J Surg Res 78 (1998) 11-17
41. Uchinami M., Muraoka R., Horiuchi T., Tabo T., Kimura N., Naito Y., et al. Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver. Surgery 124 (1998) 49-56
42. Anderson C.D., Belous A., Pierce J., Nicoud I.B., Knox C., Wakata A., et al. Mitochondrial calcium uptake regulates cold preservation-induced Bax translocation and early reperfusion apoptosis. Am J Transplant 4 (2004) 352-362
43. Belous A., Knox C., Nicoud I.B., Pierce J., Anderson C., Pinson C.W., et al. Reversed activity of mitochondrial adenine nucleotide translocator in ischemia-reperfusion. Transplantation 75 (2003) 1717-1723
44. Chen C.F., Leu F.J., Chen H.I., and Wang D. Oxygen radicals and matrix metalloproteinases mediate reperfusion liver injury. Transplant Proc 37 (2005) 4547-4549
45. Grace P.A. Ischaemia-reperfusion injury. Br J Surg 81 (1994) 637-647
46. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159-163
47. Jaeschke H., and Farhood A. Kupffer cell activation after no-flow ischemia versus hemorrhagic shock. Free Radic Biol Med 33 (2002) 210-219
48. Menger M.D., Richter S., Yamauchi J., and Vollmar B. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 46 Suppl. 2 (1999) 1452-1457
49. Jang J.H., Kang K.J., Kang Y., Lee I.S., Graf R., and Clavien P.A. Ischemic preconditioning and intermittent clamping confer protection against ischemic injury in the cirrhotic mouse liver. Liver Transpl 14 (2008) 980-988
50. Yadav S.S., Sindram D., Perry D.K., and Clavien P.A. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 30 (1999) 1223-1231
51. Clavien P.A., Selzner M., Rudiger H.A., Graf R., Kadry Z., Rousson V., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238 (2003) 843-850 [discussion, p. 851-842]
52. Kim Y.I., Fujita S., Hwang Y.J., Chun J.M., Song K.E., and Chun B.Y. Successful intermittent application of the Pringle maneuver for 30 minutes during human hepatectomy: a clinical randomized study with use of a protease inhibitor. Hepatogastroenterology 54 (2007) 2055-2060
53. Shimoda M., Iwasaki Y., Sawada T., and Kubota K. Protective effect of ischemic preconditioning against liver injury after major hepatectomy using the intermittent Pringle maneuver in swine. Pathobiology 74 (2007) 42-49
54. Capussotti L., Nuzzo G., Polastri R., Giuliante F., Muratore A., and Giovannini I. Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis. Results of a prospective, randomized clinical trial. Hepatogastroenterology 50 (2003) 1073-1077
55. Capussotti L., Muratore A., Ferrero A., Massucco P., Ribero D., and Polastri R. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg 93 (2006) 685-689
56. Ku Y., Kusunoki N., Shiotani M., Maeda I., Iwasaki T., Tominaga M., et al. Stimulation of haematogenous liver metastases by ischaemia-reperfusion in rats. Eur J Surg 165 (1999) 801-807
57. Yoshida M., Horiuchi T., Uchinami M., Tabo T., Kimura N., Yokomachi J., et al. Intermittent hepatic ischemia-reperfusion minimizes liver metastasis in rats. J Surg Res 111 (2003) 255-260
58. Weitz J., Koch M., Kienle P., Schrodel A., Willeke F., Benner A., et al. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg 232 (2000) 66-72
59. Sarli L., Pietra N., Carreras F., Longinotti E., Gafa M., and Peracchia A. Occult hepatic metastases from colorectal carcinoma: diagnostic and prognostic considerations. G Chir 12 (1991) 232-236
60. Ishizawa T., Yamamoto T., and Sekikawa T. The diagnostic values of measuring the liver volume in detecting occult hepatic metastases from colorectal cancer. Hepatogastroenterology 54 (2007) 514-517
61. Linnemann U., Schimanski C.C., Gebhardt C., and Berger M.R. Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Int J Colorectal Dis 19 (2004) 380-386
62. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2 (2002) 38-47
63. Brahimi-Horn C., Berra E., and Pouyssegur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol 11 (2001) S32-36
64. Yoong K.F., Afford S.C., Randhawa S., Hubscher S.G., and Adams D.H. Fas/Fas ligand interaction in human colorectal hepatic metastases: a mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol 154 (1999) 693-703
65. Man K., Fan S.T., Lo C.M., Liu C.L., Fung P.C., Liang T.B., et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 237 (2003) 256-264
66. Man K., Lee T.K., Liang T.B., Lo C.M., Fung P.C., Tsui S.H., et al. FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. Ann Surg 240 (2004) 159-168
67. Man K., Lo C.M., Lee T.K., Li X.L., Ng I.O., and Fan S.T. Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl 9 (2003) 425-432